{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:54:25Z","timestamp":1793750065513,"version":"4.6.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ERN-skin"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Long-term sequelae are frequent and often disabling after epidermal necrolysis (Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)). However, consensus on the modalities of management of these sequelae is lacking.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>We conducted an international multicentric DELPHI exercise to establish a multidisciplinary expert consensus to standardize recommendations regarding management of SJS\/TEN sequelae.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Participants were sent a survey via the online tool \u201cSurvey Monkey\u201d consisting of 54 statements organized into 8 topics: general recommendations, professionals involved, skin, oral mucosa and teeth, eyes, genital area, mental health, and allergy workup. Participants evaluated the level of appropriateness of each statement on a scale of 1 (extremely inappropriate) to 9 (extremely appropriate). Results were analyzed according to the RAND\/UCLA Appropriateness Method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fifty-two healthcare professionals participated. After the first round, a consensus was obtained for 100% of 54 initially proposed statements (disagreement index\u2009&lt;\u20091). Among them, 50 statements were agreed upon as \u2018appropriate\u2019; four statements were considered \u2018uncertain\u2019, and ultimately finally discarded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our DELPHI-based expert consensus should help guide physicians in conducting a prolonged multidisciplinary follow-up of sequelae in SJS-TEN.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-023-02631-7","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T06:32:57Z","timestamp":1677047577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5383-7096","authenticated-orcid":false,"given":"S.","family":"Ingen-Housz-Oro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Ameri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Brassard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mostaghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Paller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Didona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. H.","family":"Kaffenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Ben Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Y. H.","family":"Thong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Brezinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Milpied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. G.","family":"Mortz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Y.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sotozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gueudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. G.","family":"Fortune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Dridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tartar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Do-Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gabison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Salavastru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Setterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. T.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Delcampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Brockow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Seminario-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"J\u00f6rg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. P.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gon\u00e7alo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H.","family":"Noe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. H.","family":"Shear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Romanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P.","family":"Dodiuk-Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. G.","family":"Micheletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. S.","family":"Tiplica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rauz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. L.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. H.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. T.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Maverakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. E.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Br\u00fcggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"2631_CR1","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","volume":"390","author":"TA Duong","year":"2017","unstructured":"Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet. 2017;390:1996\u20132011.","journal-title":"Lancet"},{"key":"2631_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008;128:35\u201344.","journal-title":"J Invest Dermatol"},{"key":"2631_CR3","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/jdv.17274","volume":"35","author":"P Monnet","year":"2021","unstructured":"Monnet P, Rodriguez C, Gaudin O, Cirotteau P, Papouin B, Dereure O, et al. Towards a better understanding of adult idiopathic epidermal necrolysis: a retrospective study of 19 cases. J Eur Acad Dermatol Venereol. 2021;35:1569\u201376.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"2631_CR4","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1111\/jdv.16339","volume":"34","author":"EC Kuijper","year":"2020","unstructured":"Kuijper EC, French LE, Tensen CP, Vermeer MH, Bouwes Bavinck JN. Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN). J Eur Acad Dermatol Venereol. 2020;34(9):1957\u201371.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2631_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.annder.2020.02.010","volume":"147","author":"S Lalev\u00e9e","year":"2020","unstructured":"Lalev\u00e9e S, Contassot E, Ortonne N, Gaudin O, Ben Said B, Vocanson M, et al. Advances in understanding of the pathophysiology of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis). Ann Dermatol Venereol. 2020;147:475\u201381.","journal-title":"Ann Dermatol Venereol"},{"key":"2631_CR6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/bjd.18424","volume":"182","author":"G Chaby","year":"2020","unstructured":"Chaby G, Maldini C, Haddad C, Lebrun-Vignes B, Hemery F, Ingen-Housz-Oro S, et al. Incidence of and mortality from epidermal necrolysis (Stevens-Johnson syndrome\/toxic epidermal necrolysis) in France during 2003\u201316: a four-source capture-recapture estimate. Br J Dermatol. 2020;182:618\u201324.","journal-title":"Br J Dermatol"},{"key":"2631_CR7","first-page":"247","volume":"182","author":"T Bettuzzi","year":"2020","unstructured":"Bettuzzi T, Penso L, de Prost N, Hemery F, Hua C, Colin A, et al. Trends in mortality rates for Stevens-Johnson syndrome and toxic epidermal necrolysis: experience of a single centre in France between 1997 and 2017. Br J Dermatol. 2020;182:247\u20138.","journal-title":"Br J Dermatol"},{"key":"2631_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000;115:149\u201353.","journal-title":"J Invest Dermatol"},{"key":"2631_CR9","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/jid.2012.510","volume":"133","author":"P Sekula","year":"2013","unstructured":"Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes Bavinck JN, Halevy S, et al. Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol. 2013;133:1197\u2013204.","journal-title":"J Invest Dermatol"},{"key":"2631_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1001\/archderm.136.3.323","volume":"136","author":"I Garcia-Doval","year":"2000","unstructured":"Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC. Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol. 2000;136:323\u20137.","journal-title":"Arch Dermatol"},{"key":"2631_CR11","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/bjd.18294","volume":"182","author":"C Traikia","year":"2020","unstructured":"Traikia C, Hua C, Le Cleach L, de Prost N, Hemery F, Bettuzzi T, et al. Individual- and hospital-level factors associated with epidermal necrolysis mortality: a nationwide multilevel study, France, 2012\u20132016. Br J Dermatol. 2020;182:900\u20136.","journal-title":"Br J Dermatol"},{"key":"2631_CR12","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/bjd.14530","volume":"174","author":"D Creamer","year":"2016","unstructured":"Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JKG, et al. U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016. Br J Dermatol. 2016;174:1194\u2013227.","journal-title":"Br J Dermatol"},{"key":"2631_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13023-018-0793-7","volume":"13","author":"S Ingen-Housz-Oro","year":"2018","unstructured":"Ingen-Housz-Oro S, Duong TA, Bensaid B, Bellon N, de Prost N, Lu D, et al. Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins). Orphanet J Rare Dis. 2018;13:56.","journal-title":"Orphanet J Rare Dis"},{"key":"2631_CR14","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jaad.2020.02.066","volume":"82","author":"L Seminario-Vidal","year":"2020","unstructured":"Seminario-Vidal L, Kroshinsky D, Malachowski SJ, Sun J, Markova A, Beachkofsky TM, et al. Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults. J Am Acad Dermatol. 2020;82:1553\u201367.","journal-title":"J Am Acad Dermatol"},{"key":"2631_CR15","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/bjd.19893","volume":"185","author":"MC Br\u00fcggen","year":"2021","unstructured":"Br\u00fcggen MC, Le ST, Walsh S, Toussi A, de Prost N, Ranki A, et al. Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus. Br J Dermatol. 2021;185:616\u201326.","journal-title":"Br J Dermatol"},{"key":"2631_CR16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/bjd.15360","volume":"177","author":"HY Lee","year":"2017","unstructured":"Lee HY, Walsh SA, Creamer D. Long-term complications of Stevens-Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN): the spectrum of chronic problems in patients who survive an episode of SJS\/TEN necessitates multidisciplinary follow-up. Br J Dermatol. 2017;177:924\u201335.","journal-title":"Br J Dermatol"},{"key":"2631_CR17","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/bjd.18387","volume":"182","author":"S Ingen-Housz-Oro","year":"2020","unstructured":"Ingen-Housz-Oro S, Alves A, Colin A, Ouedraogo R, Layese R, Canoui-Poitrine F, et al. Health-related quality of life and long-term sequelae in survivors of epidermal necrolysis: an observational study of 57 patients. Br J Dermatol. 2020;182:916\u201326.","journal-title":"Br J Dermatol"},{"key":"2631_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/bjd.18023","volume":"181","author":"C Hajj","year":"2019","unstructured":"Hajj C, Ezzedine K, Thorel D, Delcampe A, Royer G, Hua C, et al. Disabling ocular sequelae of epidermal necrolysis: risk factors during the acute phase and associated sequelae. Br J Dermatol. 2019;181:421\u20132.","journal-title":"Br J Dermatol"},{"key":"2631_CR19","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/bjd.17267","volume":"180","author":"L Hefez","year":"2019","unstructured":"Hefez L, Zaghbib K, Sbidian E, Valeyrie-Allanore L, Allain M, Duong TA, et al. Post-traumatic stress disorder in Stevens-Johnson syndrome and toxic epidermal necrolysis: prevalence and risk factors. A prospective study of 31 patients. Br J Dermatol. 2019;180:1206\u201313.","journal-title":"Br J Dermatol"},{"key":"2631_CR20","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/bjd.14799","volume":"175","author":"RP Dodiuk-Gad","year":"2016","unstructured":"Dodiuk-Gad RP, Olteanu C, Feinstein A, Hashimoto R, Alhusayen R, Whyte-Croasdaile S, et al. Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 2016;175:422\u20134.","journal-title":"Br J Dermatol"},{"key":"2631_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2340\/00015555-2295","volume":"96","author":"CW Yang","year":"2016","unstructured":"Yang CW, Cho YT, Chen KL, Chen YC, Song HL, Chu CY. Long-term sequelae of Stevens-Johnson syndrome\/toxic epidermal necrolysis. Acta Derm Venereol. 2016;96:525\u20139.","journal-title":"Acta Derm Venereol"},{"key":"2631_CR22","volume-title":"The RAND\/UCLA appropriateness method user's manual","author":"K Fitch","year":"2001","unstructured":"Fitch K, Bernstein S, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, van het Loo M, McDonnell J, Vader JP, Kahan JP. The RAND\/UCLA appropriateness method user\u2019s manual. Santa Monica: RAND Corporation; 2001."},{"key":"2631_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000358295","volume":"228","author":"A Isvy-Joubert","year":"2014","unstructured":"Isvy-Joubert A, Ingen-Housz-Oro S, Vincent R, Haddad C, Valeyrie-Allanore L, Chosidow O, et al. Severe cutaneous adverse reactions to drugs: from patients to the national office for compensation of medical accidents. Dermatology (Basel). 2014;228:338\u201343.","journal-title":"Dermatology (Basel)"},{"key":"2631_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/jamadermatol.2020.4664","volume":"157","author":"SB Lian","year":"2021","unstructured":"Lian SB, Oh CC, Yeo YW, Lee HY. Spectrum of nail sequelae in Stevens-Johnson syndrome and toxic epidermal necrolysis. JAMA Dermatol. 2021;157:117\u20139.","journal-title":"JAMA Dermatol"},{"key":"2631_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000443164","volume":"232","author":"M Habre","year":"2016","unstructured":"Habre M, Ortonne N, Colin A, Meningaud JP, Chosidow O, Wolkenstein P, et al. Facial scars following toxic epidermal necrolysis: role of adnexal involvement? Dermatology (Basel). 2016;232:220\u20133.","journal-title":"Dermatology (Basel)"},{"key":"2631_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/jdv.16891","volume":"35","author":"JP Lefaucheur","year":"2021","unstructured":"Lefaucheur JP, Valeyrie-Allanore L, Ng Wing Tin S, Abgrall G, Colin A, Hajj C, et al. Chronic pain: a long-term sequela of epidermal necrolysis (Stevens-Johnson syndrome\/toxic epidermal necrolysis) - prevalence, clinical characteristics and risk factors. J Eur Acad Dermatol Venereol. 2021;35:188\u201394.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2631_CR27","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/archdermatol.2009.233","volume":"145","author":"F Gaultier","year":"2009","unstructured":"Gaultier F, Rochefort J, Landru MM, Allanore L, Naveau A, Roujeau JC, et al. Severe and unrecognized dental abnormalities after drug-induced epidermal necrolysis. Arch Dermatol. 2009;145:1332\u20133.","journal-title":"Arch Dermatol"},{"key":"2631_CR28","first-page":"45","volume":"11","author":"A Villa","year":"2015","unstructured":"Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag. 2015;11:45\u201351.","journal-title":"Ther Clin Risk Manag"},{"key":"2631_CR29","first-page":"157","volume":"145","author":"J Gueudry","year":"2009","unstructured":"Gueudry J, Roujeau JC, Binaghi M, Soubrane G, Muraine M. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol. 2009;145:157\u201362.","journal-title":"Arch Dermatol"},{"key":"2631_CR30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1089\/jop.2012.0009","volume":"29","author":"P Prabhasawat","year":"2013","unstructured":"Prabhasawat P, Tesavibul N, Karnchanachetanee C, Kasemson S. Efficacy of cyclosporine 0.05% eye drops in Stevens Johnson syndrome with chronic dry eye. J Ocul Pharmacol Ther. 2013;29:372\u20137.","journal-title":"J Ocul Pharmacol Ther"},{"key":"2631_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","volume":"13","author":"KH Wan","year":"2015","unstructured":"Wan KH, Chen LJ, Young AL. Efficacy and safety of topical 0.05% cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf. 2015;13:213\u201325.","journal-title":"Ocul Surf"},{"key":"2631_CR32","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ajo.2012.12.009","volume":"155","author":"YJ Lee","year":"2013","unstructured":"Lee YJ, Kim SW, Seo KY. Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases. Am J Ophthalmol. 2013;155:804\u201313.","journal-title":"Am J Ophthalmol"},{"key":"2631_CR33","doi-asserted-by":"publisher","first-page":"DES80","DOI":"10.1167\/iovs.18-24019","volume":"59","author":"C Sotozono","year":"2018","unstructured":"Sotozono C, Ueta M, Yokoi N. Severe dry eye with combined mechanisms is involved in the ocular sequelae of SJS\/TEN at the chronic stage. Invest Ophthalmol Vis Sci. 2018;59:DES80-6.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2631_CR34","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ajo.2009.07.006","volume":"148","author":"B Tougeron-Brousseau","year":"2009","unstructured":"Tougeron-Brousseau B, Delcampe A, Gueudry J, Vera L, Doan S, Hoang-Xuan T, et al. Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Am J Ophthalmol. 2009;148:852-859.e2.","journal-title":"Am J Ophthalmol"},{"key":"2631_CR35","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ajo.2014.07.012","volume":"158","author":"C Sotozono","year":"2014","unstructured":"Sotozono C, Yamauchi N, Maeda S, Kinoshita S. Tear exchangeable limbal rigid contact lens for ocular sequelae resulting from Stevens-Johnson syndrome or toxic epidermal necrolysis. Am J Ophthalmol. 2014;158:983\u201393.","journal-title":"Am J Ophthalmol"},{"key":"2631_CR36","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S0161-6420(95)30980-3","volume":"102","author":"I Tugal-Tutkun","year":"1995","unstructured":"Tugal-Tutkun I, Akova YA, Foster CS. Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology. 1995;102:576\u201385.","journal-title":"Ophthalmology"},{"key":"2631_CR37","first-page":"81","volume":"4","author":"DJ Kaser","year":"2011","unstructured":"Kaser DJ, Reichman DE, Laufer MR. Prevention of vulvovaginal sequelae in stevens-johnson syndrome and toxic epidermal necrolysis. Rev Obstet Gynecol. 2011;4:81\u20135.","journal-title":"Rev Obstet Gynecol"},{"key":"2631_CR38","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jpag.2021.03.011","volume":"34","author":"M Holtz","year":"2021","unstructured":"Holtz M, Grimstad F, Higgins J, Denny G, Strickland J, Dowlut-McElroy T. Vulvovaginal involvement in pediatric Stevens-Johnson syndrome: a case series. J Pediatr Adolesc Gynecol. 2021;34:745\u20138.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2631_CR39","doi-asserted-by":"publisher","first-page":"490.e1","DOI":"10.1016\/j.jpurol.2017.01.018","volume":"13","author":"JP Van Batavia","year":"2017","unstructured":"Van Batavia JP, Chu DI, Long CJ, Jen M, Canning DA, Weiss DA. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Pediatr Urol. 2017;13:490.e1-490.e7.","journal-title":"J Pediatr Urol"},{"key":"2631_CR40","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5001\/omj.2017.82","volume":"32","author":"G Boyraz","year":"2017","unstructured":"Boyraz G, Basaran D, Salman MC, Ozgul N, Yuce K. Vaginal reconstruction for vaginal obliteration secondary to stevens johnson syndrome: a case report and review of literature. Oman Med J. 2017;32:436\u20139.","journal-title":"Oman Med J"},{"key":"2631_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"2631_CR42","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.burns.2019.11.021","volume":"46","author":"M Harorani","year":"2020","unstructured":"Harorani M, Davodabady F, Masmouei B, Barati N. The effect of progressive muscle relaxation on anxiety and sleep quality in burn patients: a randomized clinical trial. Burns. 2020;46:1107\u201313.","journal-title":"Burns"},{"key":"2631_CR43","first-page":"15","volume":"45","author":"N Hornsby","year":"2020","unstructured":"Hornsby N, Blom L, Sengoelge M. Psychosocial interventions targeting recovery in child and adolescent burns: a systematic review. J Pediatr Psychol. 2020;45:15\u201333.","journal-title":"J Pediatr Psychol"},{"key":"2631_CR44","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/bjd.13505","volume":"172","author":"TA Duong","year":"2015","unstructured":"Duong TA, de Prost N, Ingen-Housz-Oro S, Carri\u00e9 AS, Zerah F, Valeyrie-Allanore L, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: follow-up of pulmonary function after remission. Br J Dermatol. 2015;172:400\u20135.","journal-title":"Br J Dermatol"},{"key":"2631_CR45","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/ced.13969","volume":"44","author":"EL Seccombe","year":"2019","unstructured":"Seccombe EL, Ardern-Jones M, Walker W, Austin S, Taibjee S, Williams S, et al. Bronchiolitis obliterans as a long-term sequela of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Clin Exp Dermatol. 2019;44:897\u2013902.","journal-title":"Clin Exp Dermatol"},{"key":"2631_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1600-0536.1996.tb02364.x","volume":"35","author":"P Wolkenstein","year":"1996","unstructured":"Wolkenstein P, Chosidow O, Fl\u00e9chet ML, Robbiola O, Paul M, Dum\u00e9 L, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Derm. 1996;35:234\u20136.","journal-title":"Contact Derm"},{"key":"2631_CR47","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/bjd.12125","volume":"168","author":"A Barbaud","year":"2013","unstructured":"Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M, et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol. 2013;168:555\u201362.","journal-title":"Br J Dermatol"},{"key":"2631_CR48","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1468-3083.2011.04418.x","volume":"27","author":"YT Lin","year":"2013","unstructured":"Lin YT, Chang YC, Hui RCY, Yang CH, Ho HC, Hung SI, et al. A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions. J Eur Acad Dermatol Venereol. 2013;27:356\u201364.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2631_CR49","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/bjd.12125","volume":"168","author":"A Barbaud","year":"2013","unstructured":"Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M, et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol. 2013;168:555\u201362.","journal-title":"Br J Dermatol"},{"key":"2631_CR50","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1111\/j.1398-9995.2007.01553.x","volume":"62","author":"Y Kano","year":"2007","unstructured":"Kano Y, Hirahara K, Mitsuyama Y, Takahashi R, Shiohara T. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy. 2007;62:1439\u201344.","journal-title":"Allergy"},{"key":"2631_CR51","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaci.2018.10.030","volume":"143","author":"EJ Phillips","year":"2019","unstructured":"Phillips EJ, Bigliardi P, Bircher AJ, Broyles A, Chang YS, Chung WH, et al. Controversies in drug allergy: testing for delayed reactions. J Allergy Clin Immunol. 2019;143:66\u201373.","journal-title":"J Allergy Clin Immunol"},{"key":"2631_CR52","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/cod.14063","volume":"86","author":"A Barbaud","year":"2022","unstructured":"Barbaud A, Castagna J, Soria A. Skin tests in the work-up of cutaneous adverse drug reactions: a review and update. Contact Dermat. 2022;86:344\u201356.","journal-title":"Contact Dermat"},{"key":"2631_CR53","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.2174\/1381612825666191107104126","volume":"25","author":"MM Bergmann","year":"2019","unstructured":"Bergmann MM, Caubet JC. Role of in vivo and in vitro tests in the Diagnosis of severe cutaneous adverse reactions (SCAR) to drug. Curr Pharm Des. 2019;25:3872\u201380.","journal-title":"Curr Pharm Des"},{"key":"2631_CR54","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/all.14062","volume":"75","author":"T Bell\u00f3n","year":"2020","unstructured":"Bell\u00f3n T, Rodr\u00edguez-Mart\u00edn S, Caba\u00f1as R, Ram\u00edrez E, Lerma V, Gonz\u00e1lez-Herrada C, et al. Assessment of drug causality in Stevens-Johnson syndrome\/toxic epidermal necrolysis: concordance between lymphocyte transformation test and ALDEN. Allergy. 2020;75:956\u20139.","journal-title":"Allergy"},{"key":"2631_CR55","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.intimp.2018.08.010","volume":"63","author":"P Kumkamthornkul","year":"2018","unstructured":"Kumkamthornkul P, Udnaen S, Tansit T, Tuchinda P, Srinoulprasert Y. Evaluation of a lymphocyte transformation test and cytokine detection assay to identify phenytoin and carbamazepine provoked DRESS or SJS\/TEN in epilepsy patients. Int Immunopharmacol. 2018;63:204\u201310.","journal-title":"Int Immunopharmacol"},{"key":"2631_CR56","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.jaip.2017.09.004","volume":"6","author":"JA Trubiano","year":"2018","unstructured":"Trubiano JA, Strautins K, Redwood AJ, Pavlos R, Konvinse KC, Aung AK, et al. The combined utility of ex vivo IFN-\u03b3 release enzyme-linked immunospot assay and in vivo skin testing in patients with antibiotic-associated severe cutaneous adverse reactions. J Allergy Clin Immunol Pract. 2018;6:1287-1296.e1.","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02631-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02631-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02631-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T07:06:32Z","timestamp":1677049592000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02631-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2631"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02631-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,22]]},"assertion":[{"value":"22 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}